Ontology highlight
ABSTRACT:
SUBMITTER: Altinok Gunes B
PROVIDER: S-EPMC9833301 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
Altinok Gunes Buket B Hekmatshoar Yalda Y Ozkan Tulin T Bozkurt Sureyya S Erdogan Aydos O Sena OS Buyukasik Yahya Y Aladag Elifcan E Sunguroglu Asuman A
Mediterranean journal of hematology and infectious diseases 20230101 1
Chronic myeloid leukemia (CML) is a malignant hematopoietic stem cell disease resulting in the fusion of BCR and ABL genes and characterized by the presence of the reciprocal translocation t(9;22)(q34;q11). BCR-ABL, a product of the BCR-ABL fusion gene, is a structurally active tyrosine kinase and plays an important role in CML disease pathogenesis. Imatinib mesylate (IMA) is a strong and selective BCR-ABL tyrosine kinase inhibitor. Although IMA therapy is an effective treatment, patients may de ...[more]